T0	Participants 112 128	moderate asthma.
T1	Participants 287 293	asthma
T2	Participants 428 508	patients with moderate asthma previously treated with an inhaled corticosteroid.
T3	Participants 611 822	342 adolescent and adult patients with moderate asthma [forced expiratory volume in 1 second (FEV1) between 50% and 80% of predicted] treated previously by beclomethasone dipropionate or triamcinolone acetonide.
T4	Participants 1997 2027	patients with moderate asthma.